ARCHIMED, a global healthcare private equity firm, has finalized its acquisition of Standard BioTools' Microfluidics Business, which will now operate independently as Biomark Scientific. Biomark Scientific specializes in automated genomic workflows using proprietary microfluidics technology, including the advanced Biomark X9 system. This acquisition aims to enhance Biomark's capabilities and expand its presence in genomics, clinical research, and public health markets. The company will continue serving its existing customers with the same team and improved resources under ARCHIMED's support.
ARCHIMED's acquisition of Standard BioTools' Microfluidics Business is the subject, with Pluang's Health-sector market data as of Nov 03, 2026 19:02 WIB: out of 150 priced US health stocks, 74 rose and 69 fell. Notable movers include BioNTech SE (BNTX) at USD 90.10 with a 2.94% gain and 100% buy order activity, Cogent Biosciences (COGT) at USD 30.58 with a 2.86% gain, and Brookdale Senior Living (BKD) at USD 10.16 with a 2.68% loss. The most notable figure is BNTX's 100% buy order activity on Pluang.
The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
